# the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

Study · id `cardio:ct-nct05126446` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05126446](<https://clinicaltrials.gov/study/NCT05126446>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05126446

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05126446. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-25 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05126446, source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)
- Started: 2021-07-25 (actual) (ClinicalTrials.gov record NCT05126446, source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)
- Primary completion: 2027-10-30 (anticipated) (ClinicalTrials.gov record NCT05126446, source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)
- Completion: 2028-03-30 (anticipated) (ClinicalTrials.gov record NCT05126446, source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05126446, source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05126446-2024-07-23`, retrieved 2026-11-18)

## The registry's words

- Brief title: the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
- Condition: Aortic Dissection
- Intervention (Device): the Aorta Arch Stent Graft System combined with the Endovascular Needle System
- Lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. (`cardio:org-lifetech-scientific-shenzhen-co-ltd`)

## Provenance

Content hash: 6656e27f4194edf79766b096dfdc1b014f3e1201955398a04d2b3167c34df94c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
